CMCR Symposia Series
The Center for Medicinal Cannabis Research (CMCR) Symposia Series seeks to provide timely evidenced-based information to professionals and the public regarding cannabis and cannabinoids.
The inaugural symposium titled "Cannabis and Health: Opportunities and Challenges in the New Era" was held on June 8, 2018. The symposium explored emerging issues related to basic and clinical cannabinoid science, public health and safety implications, and regulatory challenges in conducting cannabis research. Link to the agenda and videos from the 2018 Symposium.
In 2019, CMCR hosted a one day symposium titled "Cannabis and Health: Pragmatics, Priorities, Possibilities". Awards were given to two pioneers in the field of medicinal cannabinoid research followed by presentations describing bench-to-bedside research in the cannabis space, potential clinical insights from real-world cannabis use, and discussion on how we can work together with policymakers and funding agencies. Link to the agenda and videos from the 2019 Symposium.
In 2022, CMCR hosted a virtual two-day symposium on April 21-22, 2022 celebrating progress, policy, and partnership of medicinal cannabis research. The meeting kicked off with keynote addresses from award recipients and followed with a series of scientific presentations covering clinical and translational aspects of medicinal cannabis research alongside panel discussions on public policy, university-industry partnerships, and diversifying cannabis and cannabinoid-based medications. Link to the agenda and videos from the 2022 Symposium.
In 2023, CMCR will host a virtual two-day symposium on October 12-13, 2023 highlighting the state of science in medicinal cannabis research. Whereas the majority of current research focuses on delta-9-THC and cannabidiol, the 2023 CMCR Symposium will highlight emerging clinical and translational research on the "other" constituents of cannabis (minor cannabinoids, terpenes, and flavonoids) and the entourage effect.